Addressing Hypertension Care in Africa Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorJohns Hopkins University
About this trial
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
Eligibility criteria
Qualifiers
Aged 18 -70 years.
Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis.
Hypertension treatment naive or on monotherapy.
Receives primary care at one of the participating sites.
Disqualifiers
Age <18 years or >70 years.
Severely elevated BP (≥180/110mmHg).
Diagnosis of stroke, coronary artery disease, or kidney disease.
Diagnosis of end-stage renal disease (ESRD) treated with dialysis.
Trial design
Treatments tested in this trial
- ADHINCRA Program
Treatment groups
800 Participants
are divided into 4 treatment groupsLocations
17Ghana
Dominase SDA Hospital BekwaiAshanti Region, Ghana
Kumasi South Hospital KumasiAshanti Region, Ghana
Manhyia Government Hospital KumasiAshanti Region, Ghana
Tafo Government Hospital TafoAshanti Region, Ghana
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov